| Cara Alexandria Watts, MD | |
|
1740 W Taylor St, Chicago, IL 60612-7232 | |
| (866) 600-2273 | |
| Not Available |
| Full Name | Cara Alexandria Watts |
|---|---|
| Gender | Female |
| Speciality | Otolaryngology |
| Experience | 13 Years |
| Location | 1740 W Taylor St, Chicago, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477842342 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 0101260587 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Riverside Regional Medical Center | Newport news, VA | Hospital |
| Sentara Obici Hospital | Suffolk, VA | Hospital |
| Sentara Virginia Beach General Hospital | Virginia beach, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Chesapeake Bay Ent Pc | 4486715018 | 9 |
News Archive
Sports nutrition recommendations may undergo a significant shift after research from the University of Stirling has found individuals with more muscle mass do not need more protein after resistance exercise.
Researchers in South Africa and the UK have identified alpaca-derived nanoantibodies that potently neutralize variants of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
Medica today announced the launch of the Medica Research Institute as a non-profit company that will serve as the research arm within the broader organization. Built on the principals of systematic investigation, some potential areas of study include health services research, comparative effectiveness research and clinical trial studies.
Otonomy, Inc. announced today that it has completed a $10 million Series A financing with Avalon Ventures. Proceeds from the financing will be used to support the ongoing clinical trial for OTO-104 in Meniere's disease, initiate IND-enabling studies for OTO-203, and continue early-stage development of a third program.
Old people are less likely to die if they receive regular home visits from health professionals.
› Verified 9 days ago
| Entity Name | Riverside Physician Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194929026 PECOS PAC ID: 5092608448 Enrollment ID: O20040207000400 |
News Archive
Sports nutrition recommendations may undergo a significant shift after research from the University of Stirling has found individuals with more muscle mass do not need more protein after resistance exercise.
Researchers in South Africa and the UK have identified alpaca-derived nanoantibodies that potently neutralize variants of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
Medica today announced the launch of the Medica Research Institute as a non-profit company that will serve as the research arm within the broader organization. Built on the principals of systematic investigation, some potential areas of study include health services research, comparative effectiveness research and clinical trial studies.
Otonomy, Inc. announced today that it has completed a $10 million Series A financing with Avalon Ventures. Proceeds from the financing will be used to support the ongoing clinical trial for OTO-104 in Meniere's disease, initiate IND-enabling studies for OTO-203, and continue early-stage development of a third program.
Old people are less likely to die if they receive regular home visits from health professionals.
› Verified 9 days ago
| Entity Name | Chesapeake Bay Ent Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013106541 PECOS PAC ID: 4486715018 Enrollment ID: O20081201000695 |
News Archive
Sports nutrition recommendations may undergo a significant shift after research from the University of Stirling has found individuals with more muscle mass do not need more protein after resistance exercise.
Researchers in South Africa and the UK have identified alpaca-derived nanoantibodies that potently neutralize variants of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
Medica today announced the launch of the Medica Research Institute as a non-profit company that will serve as the research arm within the broader organization. Built on the principals of systematic investigation, some potential areas of study include health services research, comparative effectiveness research and clinical trial studies.
Otonomy, Inc. announced today that it has completed a $10 million Series A financing with Avalon Ventures. Proceeds from the financing will be used to support the ongoing clinical trial for OTO-104 in Meniere's disease, initiate IND-enabling studies for OTO-203, and continue early-stage development of a third program.
Old people are less likely to die if they receive regular home visits from health professionals.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Cara Alexandria Watts, MD 856 J Clyde Morris Blvd, Ste A, Newport News, VA 23601-1318 Ph: (757) 316-5900 | Cara Alexandria Watts, MD 1740 W Taylor St, Chicago, IL 60612-7232 Ph: (866) 600-2273 |
News Archive
Sports nutrition recommendations may undergo a significant shift after research from the University of Stirling has found individuals with more muscle mass do not need more protein after resistance exercise.
Researchers in South Africa and the UK have identified alpaca-derived nanoantibodies that potently neutralize variants of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
Medica today announced the launch of the Medica Research Institute as a non-profit company that will serve as the research arm within the broader organization. Built on the principals of systematic investigation, some potential areas of study include health services research, comparative effectiveness research and clinical trial studies.
Otonomy, Inc. announced today that it has completed a $10 million Series A financing with Avalon Ventures. Proceeds from the financing will be used to support the ongoing clinical trial for OTO-104 in Meniere's disease, initiate IND-enabling studies for OTO-203, and continue early-stage development of a third program.
Old people are less likely to die if they receive regular home visits from health professionals.
› Verified 9 days ago
Dr. Mausumi Natalie Syamal, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1611 W Harrison St, Chicago, IL 60612 Phone: 312-563-4100 | |
Laura Anna Petrauskas, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 5841 S Maryland Ave # Mc1035, Chicago, IL 60637 Phone: 630-254-6305 | |
Dr. Whitney E. Liddy, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 676 N Saint Clair St, Suite 15-200, Chicago, IL 60611 Phone: 312-695-4679 | |
Robert Kern, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 680 N Lake Shore Dr, Suite 1000, Chicago, IL 60611 Phone: 312-695-9797 | |
Dr. Elias M Michaelides, M. D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1611 W Harrison St Ste 550, Chicago, IL 60612 Phone: 312-942-6100 | |
Dr. Stephen Yeh Jr., M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 3860 West Ogden Avenue, Chicago, IL 60623 Phone: 872-588-3000 Fax: 847-998-0483 | |
Aimee Adair Kennedy, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 5841 S Maryland Ave, Mc 1035, E-102, Chicago, IL 60637 Phone: 773-795-3158 |